In malignant melanoma, activation of TRPM8 blocks the activation of vascular endothelial growth factor (VEGF) on TRPV1, thus inhibiting VEGF-induced neovascularization and melanoma growth [49]. The gene discussed is TRPV1; the disease is melanoma.